Join AlphaMaven

The Home Of Managed Futures

Register For Free Learn More Contact Us

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Managed Futures Dashboard:

Click to subscribe to our Free Daily Newsletter

Top Managed Futures News, Listings, Member Posts, Managed Futures Daily Indices and more!

TTU136: Philip Seager, Head of Absolute Return at Capital Fund Management
1yr ago Managed Futures toptradersunplugged Views: 679

IT's TRUE – most CIO's read 50+ books each year – get your copy of the Ultimate Guide to the Best Investment Books ever written here.

And you can get a free copy of my latest book “The Many Flavors of Trend Following” here.

Learn more about the Trend Barometer here.

And please share this episode with a like-minded friend and leave an honest rating & review on iTunes or Spotify so more people can discover the podcast.

Follow Niels on Twitter, LinkedIn and YouTube.

Follow Alan on Twitter.

Learn more about Capital Fund Management.

Timestamps

02:05 – Introduction to Capital Fund Management
05:32 – Their investment philosophy
12:27 – Periods of under-performance
19:13 – Trend following – a small piece?
24:58 – Do Trend Followers have a dual mandate?
31:32 – Their research process
36:22 – Enhancing a trend program
37:46 – Using machine learning
40:47 – Different types of trend followers
46:56 – Controlling the risk
51:20 – Dealing with drawdowns
54:44 – Achieving convexity
57:03 – Looking in hindsight
00:58:26 – Addressing rebalancing, capacity and fees
01:05:38 – Trend following disagreements
01:08:29 – Thanks for listening

TTU136: Philip Seager, Head of Absolute Return at Capital Fund Management on Top Traders Unplugged.


Today's Managed Futures Headlines:

Most popular| Most recent
FEATURED MEMBER POST
Andrea Alms Video:  Money In Motion 97 - The Chemotherapy Market
Private Equity BrookDell Partners #Video
Winton 25 March Delighted to join the alumni gathering of our Master of Science in Asset and Wealth Management (MAWM) Programme with Nanyang Technological University Singapore. NTU-WMI launched this programme in 2018, and it was a first-of-its-kind post-experience Master's degree with IBF subsidies of up to 70% for Singaporeans and PRs.
3d ago Managed Futures linkedin
Asset Class Scoreboard: March 2024
1w ago Managed Futures rcmalternatives
Softs Report 04/09/2024
1w ago Managed Futures blog.pricegroup
Fresh from the Trading Room: If you ain't first, you're last
1w ago Managed Futures cmegroup
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
CREATE A FREE MEMBERSHIP
View Managed Futures Listings
AlphaMaven Daily Indices
Apr MTD ROR
AlphaMaven Managed Futures Index:
1.5%
- more -
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 97 - The Chemotherapy Market
- posted by: BrookDell Partners
Oxford Algorithms AI Fund Overview Of February 2024 Performance
- posted by: Oxford Algorithms AI Fund
Andrea Alms Video:  Money In Motion 102 - Deep Dive Immunotherapy Cancer Market Part 3
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 101 - Deep Dive - Immunotherapy Cancer Market
- posted by: BrookDell Partners
Exome Worldwide Healthcare Partners - March 2024 Investor Newsletter
- posted by: Worldwide Healthcare Partners
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.